Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

42 results
Display

Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients

Kim SY, Yoon MH, Chin HS

PURPOSE: To investigate the effect of intravitreal anti-vascular endothelial growth factor (VEGF) injections on ganglion cell-inner plexiform layer (GCIPL) thickness in patients with age-related macular degeneration (AMD). METHODS: This retrospective study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparision of Hyperreflective Foci after Treatment of Diabetic Macular Edema Patients between Intravitreal Injections

Kim M, Park K, Yi MY, Lee SJ

PURPOSE: To compare the outcomes in patients with diabetic macular edema (DME) treated with intravitreal dexamethasone implants and intravitreal bevacizumab injections. METHODS: A retrospective cohort study was designed using 66 patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Short-term Effects of Intravitreal Injection of Three Modalities on Central Retinal Vein Occlusion

Jeong JS, Lee DW, Kim BS, Yoo WS, Chung IY, Park JM

PURPOSE: To report the short-term effects of intravitreal bevacizumab alone, low-dose bevacizumab combined with low-dose triamcinolone injection, and intravitreal dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) injection in patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intravitreal Injection of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration: a Systematic Review

Kang MJ, Shin SJ, Suh JK, Cho S, Tchoe H, Yang J, Jee D

PURPOSE: To compare the efficacy and safety of intravitreal injections of bevacizumab, ranibizumab, and aflibercept for the treatment of new patients with age-related macular degeneration (AMD). METHODS: We conducted an update...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Precipitation of Vancomycin and Ceftazidime on Intravitreal Injection in Endophthalmitis Patients

Noh GM, Nam KY, Lee SU, Lee SJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept

Moon TK, Ha JY, Sung MS, Park SW

PURPOSE: To evaluate long-term intraocular pressure (IOP) and risk of IOP elevation after intravitreal injection of ranibizumab or aflibercept in patients with age-related macular degeneration (AMD). METHODS: From January 2013 to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema

Lee YJ, Kim M

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Meta-analysis of Intravitreal Injection of Anti-vascular Endothelial Growth Factors for Diabetic Macular Edema

Tchoe H, Shin SJ, Suh JK, Cho S, Yang J, Kang MJ, Jee D

PURPOSE: Intravitreal aflibercept, ranibizumab, bevacizumab, and dexamethasone are the most widely used drugs in the treatment of diabetic macular edema (DME). The aim of this study was to compare the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effective Delivery of Exogenous Compounds to the Optic Nerve by Intravitreal Injection of Liposome

Lee J, Goh U, Park JH, Park SW, Heo H

PURPOSE: To improve the treatment efficiency of optic nerve diseases by delivering therapeutic materials to the optic nerve directly. METHODS: We tried to optimize liposomal composition to deliver a payload to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined Low Dose Bevacizumab-triamcinolone versus Bevacizumab Single Intravitreal Injection for Branch Retinal Vein Occlusion

Shin MH, Kang HJ, Seo JS, Chung IY

PURPOSE: To report the effects of combined low dose bevacizumab and low dose triamcinolone intravitreal injection compared with single bevacizumab intravitreal injection in patients with macular edema secondary to branch...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors Associated with Pain Following Intravitreal Injections

Shin SH, Park SP, Kim YK

PURPOSE: To investigate factors associated with pain intensity following intravitreal injection and factors that might be associated with changes in pain intensity in patients who received repeated injections. METHODS: A total...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term Efficacy of Vitrectomy for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients Treated with Intravitreal Injections

Cho IH, Park UC, Yu HG

PURPOSE: To evaluate the long-term efficacy of pars plana vitrectomy (PPV) on refractory or recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal steroid or anti-vascular endothelial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Intravitreal Injection on the Corneal Endothelium

Ryu SJ, Shin YU, Kang MH, Seong M, Cho HY

PURPOSE: To evaluate the effect of intravitreal injection on the corneal endothelium according to the injected drug. METHODS: The present study included 118 eyes of 113 patients who received intravitreal injection....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients

Min JS, Jung HC, Suh JY, Kwon YH

PURPOSE: To investigate the difference of optical coherence tomography (OCT) findings between the aflibercept treatment group and the ranibizumab treatment group. METHODS: This study includes patients diagnosed with treatment-naïve neovascular age-related...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Noninfectious Endophthalmitis after Intravitreal Injection of Aflibercept

Kim CH, Shin JS, Jeon CY, Chang YS, Lee YH

PURPOSE: To report a case of noninfectious endophthalmitis after intravitreal injection of aflibercept. CASE SUMMARY: A 67-year-old male patient presented with sudden vision loss 2 days after intravitreal aflibercept injection for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Relationship between Pain and Injection Site during Intravitreal Injection

Jeong KD, Kim JH, Kim JS, Hwang JH

PURPOSE: Using a visual analogue scale, patients pain was compared according to injection site during intravitreal injection. METHODS: A prospective, clinical trial was conducted on 171 eyes of patients experiencing age-related...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Intravitreal Injection of Bevacizumab or Ranibizumab on Systemic Circulation

Yoon MH, Kim YJ, Lee SY, Lee KW, Chin HS

PURPOSE: The purpose of this study was to evaluate the systemic effects of ranibizumab and bevacizumab by examining the plasma levels of anti-vascular endothelial growth factor (anti-VEGF) and VEGF before...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intravitreal injection of anti-vascular endothelial growth factor for patients with various retinal diseases

Kang S

Vascular endothelial growth factor (VEGF-A) is a major regulator of angiogenesis and vascular permeability. VEGF-A plays an important role in a wide variety of retinal diseases. Therefore, intravitreal injection of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Intravitreal Injection of Dexamethasone Implant during Cataract Surgery in Patients with Noninfectious Uveitis

Kim DH, Cho BJ, Chung H, Heo JW

PURPOSE: To investigate the efficacy and safety of intravitreal dexamethasone implant for controlling postoperative inflammation among uveitis patients undergoing cataract extraction. METHODS: Ten eyes with noninfectious uveitis underwent phacoemulsification with intraocular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Adult-Onset Vitelliform Dystrophy Treated with Intravitreal Injection of Bevacizumab

Moon SW, Lee HY, Yun IH, Lim SH

  • KMID: 2338818
  • J Korean Ophthalmol Soc.
  • 2014 Jul;55(7):1093-1098.
PURPOSE: To report a patient diagnosed with adult-onset vitelliform dystrophy (AOVD) who received an intravitreal injection of bevacizumab in both eyes. CASE SUMMARY: A 47-year-old female presented with blurred vision and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr